Gina Chapman
Vermögen: - $ am 30.06.2026
Vermögen: - $ am 30.06.2026
Gina Chapman currently works at Entrada Therapeutics, Inc., as Independent Director from 2023 and Verizon Capital Corp., as Manager.
Ms. Chapman also formerly worked at Cargo Therapeutics, Inc., as President, Chief Executive Officer & Director from 2022 to 2025 and Roche Group, as Senior Vice President-Business Unit Head from 2021 to 2022.
Ms. Chapman received her undergraduate degree from the University of California, Santa Barbara.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 10.06.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ENTRADA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.09.2023 |
Verizon Capital Corp.
Verizon Capital Corp. Finance/Rental/LeasingFinance Provides equipment rental and lease financing | Corporate Officer/Principal | - |
| Unternehmen | Position | Ende |
|---|---|---|
| CARO THERPAR | Vorstandsvorsitzender | 18.03.2025 |
Roche Group
Roche Group Real Estate DevelopmentFinance Manages real estate properties | Corporate Officer/Principal | 01.04.2022 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Verizon Capital Corp.
Verizon Capital Corp. Finance/Rental/LeasingFinance Provides equipment rental and lease financing | Finance |
Roche Group
Roche Group Real Estate DevelopmentFinance Manages real estate properties | Finance |
University of California, Santa Barbara
University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Entrada Therapeutics, Inc.
Entrada Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for rare neuromuscular diseases | Health Technology |
Cargo Therapeutics, Inc.
Cargo Therapeutics, Inc. BiotechnologyHealth Technology Engages in generation of adoptive cell therapies for cancer treatment | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen